Clinical trial
A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In…
NCT00463697 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00463697 |
|---|---|
| Title | A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients |
| Official title | A Randomized, Single-dose, Dose-ascending, Double Blind, Placebo-controlled, 5-way Crossover Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled Doses of GW642444M With Magnesium Stearate in Asthmatic Patients |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | GW642444H (100mcg), placebo, GW642444M (25, 100 & 400 mcg) |
| Enrollment | 20 |
| Start date | Apr 2, 2007 |
| Primary completion | Aug 4, 2007 |
| Completion | Aug 4, 2007 |
| First posted | Apr 20, 2007 |
| Last update posted | Aug 7, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: